Enlitic, Inc. (ASX:ENL)
Australia · Delayed Price · Currency is AUD 0.0090
0.00 (0.00%)
Apr 2, 2026, 3:02 PM AEST
Enlitic Revenue
In the year 2025, Enlitic had annual revenue of $3.80M USD with 251.87% growth. Enlitic had revenue of $1.91M in the half year ending December 31, 2025, with 568.83% growth.
Revenue
$3.80M
Revenue Growth
+251.87%
P/S Ratio
1.32
Revenue / Employee
n/a
Employees
n/a
Market Cap
7.50M AUD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.80M | 2.72M | 251.87% |
| Dec 31, 2024 | 1.08M | 521.18K | 93.46% |
| Dec 31, 2023 | 557.68K | -345.60K | -38.26% |
| Dec 31, 2022 | 903.28K | -390.69K | -30.19% |
| Dec 31, 2021 | 1.29M | 904.49K | 232.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Adheris Health | 40.60M |
| ImExHS | 28.97M |
| Resonance Health | 13.84M |
| Global Health | 8.46M |
| Careteq | 7.61M |
| Visionflex Group | 4.46M |
| Oakridge International | 3.12M |
| HITIQ | 1.98M |